COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess

Review highlights that many of the risk factors for lethality of COVID-19 (i.e. hypertension, diabetes) are common co-morbidities of Cushing’s syndrome, and that careful monitoring is required in this special, susceptible population.

Source:

The Lancet Diabetes & Endocrinology